✦ LIBER ✦

Risperidone Does Not Affect Steady-State Pharmacokinetics of Divalproex Sodium in Patients with Bipolar Disorder

✍ Scribed by Dr Arun Ravindran, Peter Silverstone, Denis Lacroix, Erno van Schaick, An Vermeulen, Jennifer Alexander

Book ID: 119926585
Publisher: Springer International Publishing AG
Year: 2004
Tongue: English
Weight: 125 KB
Volume: 43
Category: Article
ISSN: 0312-5963
DOI: 10.2165/00003088-200443110-00004

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A study of the steady-state pharmacokine

A study of the steady-state pharmacokinetics and safety of divalproex sodium in combination with risperidone or placebo in bipolar patients in remission

✍ A.V. Ravindran; P.H. Silverstone; D. Lacroix; E. Van Schaick; A. Vermeulen; J. A 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 145 KB

Open-label steady-state pharmacokinetic

Open-label steady-state pharmacokinetic drug interaction study on co-administered quetiapine fumarate and divalproex sodium in patients with schizophrenia, schizoaffective disorder, or bipolar disorder

✍ Helen R. Winter; C. Lindsay DeVane; Carlos Figueroa; Debra J. Ennis; Jennifer E. 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 150 KB

Steady-State Pharmacokinetics of Rivasti

Steady-State Pharmacokinetics of Rivastigmine in Patients with Mild to Moderate Alzheimer’s Disease Not Affected by Co-Administration of Memantine

✍ Shua-Haim, Joshua; Smith, Juanita; Picard, Franck; Sedek, Greg; Athalye, Sandeep 📂 Article 📅 2008 🏛 Springer International Publishing AG 🌐 English ⚖ 164 KB

A non-randomized study to investigate th

A non-randomized study to investigate the effects of the atypical antipsychotic aripiprazole on the steady-state pharmacokinetics of lamotrigine in patients with bipolar I disorder

✍ Frank C Schieber; David W Boulton; Alfred H Balch; Robert Croop; Suresh Mallikaa 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 135 KB 👁 1 views

## Abstract ## Objective To determine the effect of aripiprazole on steady‐state pharmacokinetics of lamotrigine in patients with bipolar I disorder who were clinically stable on lamotrigine (100–400 mg/day) for ≥4 weeks. ## Methods In this open‐label study, aripiprazole was administered at 10 m